Advertisement
In Brief

Karin Jooss named chief scientific officer of Gritstone Oncology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

KARIN JOOSS was named chief scientific officer of Gritstone Oncology. Jooss previously served as head of Cancer Immunotherapeutics and Immunopharmacology at Pfizer for seven years. Mojca Skoberne also joined the company as senior director of immunology. Skoberne most recently served as program lead at Genocea Biosciences, a company that identifies targets of T cell responses....

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Advertisement
Advertisement
Table of Contents
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

In Brief

David Liu awarded 2025 Breakthrough Prize in Life Sciences

Howard Hughes Medical Institute Investigator David R. Liu was awarded the 2025 Breakthrough Prize in Life Sciences for developing two gene-editing technologies—known as base editing and prime editing—which enable the correction or replacement of virtually any genetic mutation, including those that cause countless human genetic diseases. 
Advertisement
Advertisement